A comparative study of restenosis rates in bare metal and drug-eluting stents

International Journal of Angiology

Volumn 19, Issue 2, 2010, Pages

  Mohan, Shilpi ^a   Dhall, Anil ^a  

^a ARMY HOSPITAL RESEARCH AND REFERRAL   (India)

Author keywords

Armed forces; Bare metal stents; Drug eluting stents; Predictors of restenosis; Real world registry; Restenosis

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; FIBRINOGEN RECEPTOR ANTAGONIST; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

ADULT; AGE DISTRIBUTION; ANGIOCARDIOGRAPHY; ARTICLE; BARE METAL STENT; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CORONARY ARTERY RECANALIZATION; COST EFFECTIVENESS ANALYSIS; DIABETES MELLITUS; DIETARY INTAKE; DRUG ELUTING STENT; EMPLOYMENT STATUS; FAMILY HISTORY; FEMALE; HEART LEFT VENTRICLE EJECTION FRACTION; HUMAN; HYPERTENSION; IN-STENT RESTENOSIS; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; OBESITY; OUTCOME ASSESSMENT; PATIENT ATTITUDE; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; SEX DIFFERENCE; SMOKING; TREADMILL EXERCISE; TREATMENT RESPONSE; UNSTABLE ANGINA PECTORIS;

EID: 80052971903     PISSN: 10611711     EISSN: 16155939     Source Type: Journal    
DOI: 10.1055/s-0031-1278368     Document Type: Article

References (42)

1. Rupprecht HJ, Brennecke R, Bernhard G, Erbel R, Pop T, Meyer J. Analysis of risk factors for restenosis after PTCA. Cathet Cardiovasc Diagn 1990;19:151-9. (Pubitemid 20150126)
2. Macdonald RG, Henderson MA, Hirshfeld JW Jr, et al. Patient-related variables and restenosis after percutaneous transluminal coronary angioplasty - a report from the M-HEART group. Am J Cardiol 1990;66:926-31. (Pubitemid 20360583)
3. Watanabe CT, Maynard C, Ritchie JL. Comparison of short-term outcomes following coronary artery stenting in men versus women. Am J Cardiol 2001;88:848.
4. Jacobs AK, Johnston JM, Haviland A, et al. Improved outcomes for women undergoing contemporary percutaneous coronary intervention: A report from the national heart, lung, and blood institute dynamic registry. J Am Coll Cardiol 2002;39:1608.
5. Holmes DR Jr, Vlietstra RE, Smith HC, et al. Restenosis after percutaneous transluminal coronary angioplasty (PTCA): A report from the PTCA registry of the national heart, lung, and blood institute. Am J Cardiol 1984;53:77C-81C. (Pubitemid 14075393)
6. Abizaid A, Mehran R, Bucher TA, et al. Does diabetes influence clinical recurrence after coronary stent implantation? J Am Coll Cardiol 1997;29(Suppl A):A-188.
7. Aronson D, Bloomgarden Z, Rayfield EJ. Potential mechanisms promoting restenosis in diabetic patients. J Am Coll Cardiol 1996;27:528-35. (Pubitemid 26081914)
8. Gilbert J, Raboud J, Zinman B. Meta-analyis of the effect of diabetes on restenosis rates among patients receiving coronary angioplasty stenting. Diabetes Care 2004;27:990-4. (Pubitemid 38420228)
9. Bach R, Jung F, Kohsiek I, et al. Factors affecting the restenosis rate after percutaneous transluminal coronary angioplasty. Thromb Res 1994;74:S55-67. (Pubitemid 24154926)
10. Desmarais RL, Sarembock IJ, Ayers CR, Vernon SM, Powers ER, Gimple LW. Elevated serum lipoprotein(a) is a risk factor for clinical recurrence after coronary balloon angioplasty. Circulation 1995;9:1403-9.
11. Chiarugi L, Prisco D, Antonucci E, et al. Lipoprotein (a) and anticardiolipin antibodies are risk factors for clinically relevant restenosis after elective balloon percutaneous transluminal coronary angioplasty. Atherosclerosis 2001;154:129-35. (Pubitemid 32008572)
12. Rozenman Y, Gilon D, Welber S, et al. Plasma lipoproteins are not related to restenosis after successful coronary angioplasty. Am J Cardiol 1993;72:1206-7. (Pubitemid 24050065)
13. Violaris AG, Melkert R, Serruys PW. Influence of serum cholesterol and cholesterol subfractions on restenosis after successful coronary angioplasty. A quantitative angiographic analysis of 3336 lesions. Circulation 1994;90:2267-79. (Pubitemid 24354311)
14. Serruys PW, Foley DP, Jackson G, et al. A randomized placebo-controlled trial of fluvastatin for prevention of restenosis after successful coronary balloon angioplasty; final results of the fluvastatin angiographic restenosis (FLARE) trial. Eur Heart J 1999;20:58-69. (Pubitemid 29027527)
15. Schillinger M, Exner M, Mlekusch W, et al. Effect of smoking on restenosis during the 1st year after lower-limb endovascular interventions. Radiology 2004;231:831-8. (Pubitemid 38668105)
16. Belardinelli R, Paolini I, Cianci G, Piva R, Georgiou D, Purcaro A. Exercise training intervention after coronary angioplasty: The ETICA trial. J Am Coll Cardiol 2001;37:1891-900. (Pubitemid 32499976)
17. Lange H, Suryapranata H, De Luca G, et al. Folate therapy and in-stent restenosis after coronary stenting. N Engl J Med 2004;350:2673-81. (Pubitemid 38788002)
18. Rana JS, Mittleman MA, Ho KK, Cutlip DE. Obesity and clinical restenosis after coronary stent placement. Am Heart J 2005;150:821-6. (Pubitemid 41396521)
19. Tarastchuk JCE, Guérios EE, Bueno Rda R, et al. Obesity and coronary intervention: Should we continue to use body mass index as a risk factor? Arq Bras Cardiol 2008;90:284-9.
20. Nikolsky E, Kosinski E, Mishkel GJ, et al. Impact of obesity on revascularization and restenosis rates after bare-metal and drug-eluting stent implantation (from the TAXUS-IV trial). Am J Cardiol 2005;95:709-15. (Pubitemid 40332647)
21. Kastrati A, Dirschinger J, Schömig A. Genetic risk factors and restenosis after percutaneous coronary interventions. Herz 2000;25:34-46. (Pubitemid 30140175)
22. Moliterno DJ, Yakubov SJ, DiBattiste PM, et al. Outcomes at 6 months for the direct comparison of tirofiban and abciximab during percutaneous coronary revascularisation with stent placement: The TARGET follow-up study. Lancet 2002;360:355-60.
23. Leimgruber PP, Roubin GS, Hollman J, et al. Restenosis after successful coronary angioplasty in patients with single-vessel disease. Circulation 1986;73:710-7. (Pubitemid 16081430)
24. Bourassa MG, Lespérance J, Eastwood C, et al. Clinical, hysiologic, anatomic and procedural factors predictive of restenosis after percutaneous transluminal coronary angioplasty. J Am Coll Cardiol 1991;18:368-76.
25. Acute Coronary Care in the Thrombolytic Era. Ann Intern Med 1988;109:848. (Book review)
26. Bengtson JR, Mark DB, Honan MB, et al. Detection of restenosis after elective percutaneous transluminal coronary angioplasty using the exercise treadmill test. Am J Cardiol 1990;65:28-34. (Pubitemid 20013919)
27. Hillegass WB, Bengtson JR, Ancukiewicz M, et al. Pre-discharge exercise testing does not predict clinical events or restenosis after successful angioplasty. Circulation 1992;86:I-137. (Abst)
28. Laarman G, Luijten HE, van Zeyl LG, et al. Assessment of silent restenosis and long-term follow-up after successful angioplasty in single vessel coronary artery disease: The value of quantitative exercise electrocardiography and quantitative coronary angiography. J Am Coll Cardiol 1990;16:578-85. (Pubitemid 20296119)
29. Wijns W, Serruys PW, Simoons ML, et al. Predictive value of early maximal exercise test and thallium scintigraphy after successful percutaneous transluminal coronary angioplasty. Br Heart J 1985;53:194-200. (Pubitemid 15053140)
30. Azpitarte J, Tercedor L, Melgares R, Prieto JA, Romero JA, Ramírez JA. The value of exercise electrocardiography testing in the identification of coronary restenosis: A probability analysis. Int J Cardiol 1995;48:239-47.
31. Hermans WR, Rensing BJ, Kelder JC, de Feyter PJ, Serruys PW. Postangioplasty restenosis rate between segments of the major coronary arteries. Am J Cardiol 1992;69:194-200.
32. Platko WP, Hollman J, Whitlow PL, Franco I. Percutaneous transluminal angioplasty of saphenous vein graft stenosis: Long-term follow-up. J Am Coll Cardiol 1989;14:1645-50. (Pubitemid 20011853)
33. Savage MP, Douglas JS Jr, Fischman DL, et al. Stent placement compared with balloon angioplasty for obstructed coronary bypass grafts. Saphenous vein de novo trial investigators. N Engl J Med 1997;337:740-7. (Pubitemid 27417973)
34. Süselbeck T, Singh D. Direct stenting appears as effective as stenting following predilatation. Evid Based Cardiovasc Med 2006;10:119-20. (Pubitemid 43811733)
35. Mehilli J, Kastrati A, Dirschinger J, et al. Intracoronary stenting and angiographic results: Restenosis after direct stenting versus stenting with predilation in patients with symptomatic coronary artery disease (ISAR-DIRECT trial). Catheter Cardiovasc Interv 2004;61:190-5. (Pubitemid 38160616)
36. Collaborative overview of randomised trials of antiplatelet therapy - II: Maintenance of vascular graft or arterial patency by antiplatelet therapy. BMJ 1994;308:159.
37. Savage MP, Goldberg S, Bove AA, et al. Effect of thromboxane A2 blockade on clinical outcome and restenosis after successful coronary angioplasty. Multi-hospital eastern atlantic restenosis trial (M-HEART II). Circulation 1995;92:3194-200.
38. Hirshfeld JW Jr, Schwartz JS, Jugo R, et al. Restenosis after coronary angioplasty: A multivariate statistical model to relate lesion and procedure variables to restenosis. The M-HEART investigators. J Am Coll Cardiol 1991;18:647-56.
39. Rensing BJ, Hermans WR, Deckers JW, de Feyter PJ, Tijssen JG, Serruys PW. Lumen narrowing after percutaneous transluminal coronary balloon angioplasty follows a near Gaussian distribution: A quantitative angiographic study in 1,445 successfully dilated lesions. J Am Coll Cardiol 1992;19:939-45.
40. Hamasaki N, Nosaka H, Kimura T, et al. Influence of lesion length on late angiographic outcome and restenotic process after successful stent implantation. J Am Coll Cardiol 1997;29:239A. (Abst)
41. Kereiakes D, Linnemeier TJ. Usefulness of stent length in predicting in-stent restenosis (the MULTI-LINK stent trials). Am J Cardiol 2000;86:336.
42. Kaiser C, Brunner-La Rocca H, Buser PT, et al. Incremental cost-effectiveness of drug-eluting stents compared with a third-generation bare-metal stent in a real-world setting: Randomised Basel Stent Kosten Effektivitäts Trial (BASKET). Lancet 2005;366:921-9. (Pubitemid 41265666)